Monroe supports Vivo Capital’s buyout of Serán

Monroe Capital has provided a senior credit facility to back Vivo Capital's acquisition of Bend, Oregon-based Serán Bioscience Inc, a provider of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this